Core Viewpoint - The announcement indicates that Duoduo Pharmaceutical Co., Ltd. has received a notice of acceptance from the National Medical Products Administration for the consistency evaluation application of Sodium Cytidine Injection, marking a significant step in the drug's regulatory process [1] Group 1: Product Information - The drug in question is Sodium Cytidine Injection, with a specification of 2ml:0.25g (calculated as C14H26N4O11P2) [1] - The application pertains to the consistency evaluation for domestically produced drugs, which is crucial for ensuring quality and efficacy [1] Group 2: Historical Context - Sodium Cytidine Injection was approved for market release in 1987, with the approval number Guo Yao Zhun Zi H19993355 [1] - The drug is indicated for conditions such as cerebral blood supply disorders due to thrombosis or vascular rupture, particularly during acute and subacute phases, as well as for traumatic brain injuries [1] Group 3: Financial Investment - As of the date of the announcement, the project has accumulated research and development expenses totaling 2.4575 million yuan [1]

Core Viewpoint - Zhongguancun (000931.SZ) announced that its subsidiary, Duoduo Pharmaceutical Co., Ltd., has received the Acceptance Notice from the National Medical Products Administration for the consistency evaluation application of Sodium Cytidine Injection [1] Group 1: Product Information - The product under application is indicated for: 1) Cerebral blood supply disorders during the acute and subacute phases caused by thrombosis or vascular rupture 2) Conditions resulting from head trauma due to impact [1]

Core Viewpoint - The company Zhongguancun (000931.SZ) announced that its subsidiary, Duoduo Pharmaceutical Co., Ltd., has received an acceptance notice from the National Medical Products Administration for the consistency evaluation application of sodium cytidine injection [1] Group 1 - The product under application is indicated for: 1) cerebral blood supply disorders during acute and subacute phases caused by thrombosis or vascular rupture 2) conditions resulting from head trauma due to impact [1]

Core Viewpoint - Zhongguancun (000931.SZ) announced that its subsidiary, Duoduo Pharmaceutical Co., Ltd., has received the Acceptance Notice from the National Medical Products Administration for the consistency evaluation application of Sodium Oligodendrocyte Injection [1] Group 1: Product Information - The Sodium Oligodendrocyte Injection (specification: 2ml:0.25g, calculated as C14H26N4O11P2) was approved for market launch in 1987, with the drug approval number Guoyao Zhunzi H19993355 [1] - The indications for the newly submitted product include: 1) Cerebral blood supply disorders during acute and subacute phases caused by thrombosis or vascular rupture; 2) Conditions resulting from head trauma [1]

关于下属公司多多药业胞磷胆碱钠注射液一致性评价申报收到国家药品监督管理局《受理通知书》的公告 共 2 页 证券代码：000931 证券简称：中关村 公告编号：2026-015 北京中关村科技发展（控股）股份有限公司 关于下属公司多多药业胞磷胆碱钠注射液一致性评价申报 药品名称：胞磷胆碱钠注射液 剂型：注射剂 规格：2ml:0.25g（以 C14H26N4O11P2计） 申请事项：境内生产药品一致性评价 申请人：多多药业有限公司 受理号：CYHB2650042 结论：经审查，决定予以受理。 收到国家药品监督管理局《受理通知书》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 北京中关村科技发展（控股）股份有限公司（以下简称：公司）下属公司 多多药业有限公司（以下简称：多多药业）于近日收到国家药品监督管理局（以 下简称：国家药监局）签发的《受理通知书》，胞磷胆碱钠注射液一致性评价 申请获得受理，现将相关情况公告如下： 一、基本信息 多多药业的胞磷胆碱钠注射液（规格：2ml:0.25g（以 C14H26N4O11P2计）） 于 1987 年获批上市，药品批准文 ...

Core Insights - The event "Lohas Zhongguancun Science and Art Carnival" was launched on February 4, coinciding with the beginning of spring, emphasizing the integration of cultural and technological experiences for the New Year [1][3] - The event features four main sections: AI Innovation Workshop, Neighborhood Joy Gathering, Smart Play Zone, and New Village Goods Collection, catering to diverse age groups and consumer needs [3] Group 1 - The AI Innovation Workshop showcases over 20 high-quality tech companies, providing an immersive experience in cutting-edge technology [3] - Interactive exhibits include a human-machine hybrid robot, brain-machine interface experiences, and adaptive massage robots, attracting significant public interest [3][5] - Tsinghua University volunteers are providing professional product introductions and science popularization on advanced technologies like laser security, smart robots, and 3D printing [5] Group 2 - Engaging activities such as AI tennis, AI piano playing, VR moon exploration, and robot calligraphy are designed to attract families and young people [5] - The event includes hands-on activities like New Year horse-making, allowing citizens to participate for free and enhancing their festive experience [7] - The event will run until February 7, with special performances scheduled on February 4 and February 7 from 18:30 to 20:00 [7]

Core Insights - The AI + Energy Development Conference was successfully held in Beijing, marking the launch of the Zhongguancun (Haidian) AI Digital Energy Industrial Park, which aims to drive regional industrial upgrades and energy transition towards carbon neutrality [1][2] Group 1: Event Overview - The conference gathered over 300 participants, including government leaders, academicians, and representatives from leading energy companies, focusing on collaborative platforms for global intelligence and practical cooperation [1] - Key discussions revolved around technologies such as efficient computing power and clean electricity synergy, as well as intelligent control of complex energy systems [1] Group 2: Industrial Park Details - The Zhongguancun (Haidian) AI Digital Energy Industrial Park covers approximately 45,000 square meters with a total construction area of about 240,000 square meters, featuring six research office buildings and one supporting building [2] - The project began construction in August 2022 and is expected to complete its construction by January 2025, with trial operations starting in May 2025 [2] Group 3: Strategic Importance - Haidian District is positioned as a core area for Beijing's international technology innovation center, leveraging its dense AI innovation resources and strong energy industry foundation [3] - The park aims to integrate AI and digital energy, utilizing cutting-edge technologies like AI, big data, and IoT to create a modern industrial ecosystem [3] Group 4: Future Plans and Goals - The park has already attracted nearly 30 AI and digital energy technology companies within eight months, with over 50% being specialized and high-tech enterprises [4] - Future plans include establishing public technology platforms for AI chip testing and algorithm development, supporting technological innovation and development for resident companies [4] - The park aims to become a hub for innovation, industry aggregation, and result transformation in the AI and energy sectors, contributing to Beijing's goal of becoming an international technology innovation center and achieving national energy strength and carbon neutrality [4]

超强阵容集结完毕！今天19：00-22：00，锁定央视频新媒体矩阵，来《中关村对话·AI迎春夜》，与学 术泰斗、企业领袖、青年开发者、转型先锋、跨代用户，踏上一场与AI共赴春天的旅程。 A 山春夜 F 场与AI 2 3 3 ---------- 2月4日19:00-22:00 央视频新媒体矩阵播出 野佳用 第 HIST as 酸 樓 张桥峰 家 吗 日 anala Relation Production Production College College College College College College College College College Corporation Comment Comment 陈建宁 炸师哲 只 法 大 提 大 更 下 。 。 同點疑 澳 李晓兵 作出版社會出版社 ## 200 Son 生育| 洋血糖果 th 提 有 用 张昱轩 A 上張護 官网站上 起开育 网 # 时纪过 责任编辑：梁斌 SF055 超强阵容集结完毕！今天19：00-22：00，锁定央视频新媒体矩阵，来《中关村对话·AI迎春夜》，与学 术泰斗、企业领袖、青年开发者、转型先锋、跨代用户，踏上一场与 ...

中关村科技租赁公告，于2026年1月29日，公司作为买方与供应商(山东氢醇生态股份有限公司)及承租 人(山东康沃控股有限公司)订立采购协议II，据此，公司向供应商购买租赁资产III，购买价款为人民币 2835万元；及公司作为出租人与承租人订立融资租赁协议III，据此(其中包括)，公司向承租人出租租赁 资产III，租赁期为36个月，总租赁款项约为人民币2678万元。租赁资产III指甲醇发电机组。 香港联交所最新资料显示，2月3日，中关村科技租赁(01601)股东将股票存入国泰君安(香港)，存仓市值 2139.98万港元，占比5.16%。 ...

中关村科技租赁公告，于2026年1月29日，公司作为买方与供应商(山东氢醇生态股份有限公司)及承租 人(山东康沃控股有限公司)订立采购协议II，据此，公司向供应商购买租赁资产III，购买价款为人民币 2835万元；及公司作为出租人与承租人订立融资租赁协议III，据此(其中包括)，公司向承租人出租租赁 资产III，租赁期为36个月，总租赁款项约为人民币2678万元。租赁资产III指甲醇发电机组。 智通财经APP获悉，香港联交所最新资料显示，2月3日，中关村科技租赁(01601)股东将股票存入国泰君 安(香港)，存仓市值2139.98万港元，占比5.16%。 ...